Lutz Robert Matthew 4
4 · Strongbridge Biopharma plc · Filed Feb 23, 2021
Insider Transaction Report
Form 4
Lutz Robert Matthew
Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2021-02-22$3.62/sh−6,978$25,260→ 181,333 total
Footnotes (1)
- [F1]Shares withheld by Strongbridge Biopharma plc to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.